The chairman is eager to send a message for the coming year.
Release time:
2021-02-10
seize the day and seize the hour for development, and it is urgent to improve the ability.
enterprise needs to redouble its efforts. chairman
earnestly hopes to send a message to the group company's 2020 annual summary and commendation conference held on February 3, Jiang xiaomeng, secretary of the party Committee and chairman of the group company, made the topic "seize the hour for development" in view of the market situation and existing problems faced by the company in that year, the summary speech of the meeting of "ability is urgent", from three aspects of analysis and elaboration, the company's work in 2021 put forward requirements.
The current achievements are not easy to come by, and the future risks are still in sight. Jiang Xiaomeng pointed out that the peak has made good achievements in the 13th Five Year Plan period, which is not only the result of persisting in strengthening the main business, grasping the layout and attaching importance to management, but also the achievements brought about by the joint efforts of all the peak people. However, the current China is facing a century of unprecedented changes, the world pattern has undergone great changes, the new coronary pneumonia epidemic global pandemic to accelerate the evolution of this great change, economic globalization encountered a countercurrent, economic downturn, and is entering a period of turbulent change, the economic situation is changing very fast. Under the new pattern of taking the domestic big cycle as the main body and the domestic and international double cycle, enterprises must grasp the "new rhythm" of the market and lay a good "advance quantity". Enterprises that meet the status quo and rest on their laurels will be eliminated by the market at any time. Judging from the situation of the peak itself, with the progress of the industry and the integration of enterprises, the existing advantages of the two main businesses have been overtaken or are being overtaken. What we can do is to establish a correct and realistic development direction as the premise, seize opportunities, make scientific layout, take the initiative to innovate, vigorously develop, solve problems in development through development, and enhance the core competitive advantages of enterprises through innovation.
Grasp the development and seize every minute. It is urgent to improve the ability. Jiang Xiaomeng believes that the next five years will be the historical intersection of the implementation of the 14th Five-Year Plan and the two 100-year goals. The economic work conferences of the Central Committee, Zhejiang Provincial Committee and Jinhua Municipal Committee have pointed out the direction for economic and social development at their respective levels. Enterprise managers must deeply understand the spirit of the relevant meetings and find out the focus of future development. Improve the organizational competitiveness, product competitiveness, innovation competitiveness, cultural competitiveness and talent competitiveness of the group company in an all-round way. From the perspective of the two main businesses of the peak, the problem of cement overcapacity has existed for a long time, and the best way to solve the problem of excess is merger and reorganization and transformation and upgrading to improve industrial concentration and market competitiveness. The peak cement sector should also seize the current opportunity to step up the layout. In the pharmaceutical industry, with the in-depth implementation of policies such as medical insurance negotiations and volume procurement, the competitive pressure of production enterprises has increased sharply. Peak Pharmaceutical must seize the time to build the cost and quality advantages of the production system in an all-round way, and use the speed, quality, curative effect and exclusive advantages in the field of innovative drugs to create the comparative competitive advantage of Peak Pharmaceutical.
The future of the enterprise is promising. We need to redouble our efforts. Jiang Xiaomeng pointed out that for the peak, only by doing familiar industries, doing good work, and making products with core competitiveness can we get better development. How to recreate advantages? The cement sector should speed up the rational layout, seize the advantages of resources, improve labor productivity through intelligent transformation, reduce costs and efficiency, reduce emissions through continuous upgrading of processes, and establish competitive advantages through the extension of the industrial chain such as aggregate production and solid hazardous waste treatment. The pharmaceutical industry should strengthen the introduction of innovative drugs and exclusive drugs to obtain incomparable product advantages. Taking advantage of the existing conditions for the integration of bulk drugs and preparations, the cost of centralized products should be minimized to ensure the competitive advantage in joint centralized procurement. Taking advantage of the tightening of environmental protection management and the tightening of approval for the production of bulk drugs, the cake of pharmaceutical intermediates and bulk drugs should be enlarged to create the second peak pharmaceutical industry.
For the specific work in 2021, Jiang Xiaomeng has made key requirements on the following aspects: strictly implement the company's annual work plan, layer upon layer of responsibilities, and ensure the completion of the target; Establish the concept of "everything for sales", improve the quality of operation, enhance the stickiness of customers, realize the advancement of sales, continuously improve the level of customer service, and achieve high returns with efficient management, high-quality service and high-quality products; Grasp the market demand, take the initiative to seize opportunities, speed up the layout of the cement industry and enhance competitiveness; adhere to innovation-driven and technology-led, seize the commanding heights of intelligent manufacturing, cement enterprises should build intelligent factories with high standards, and the pharmaceutical industry should strengthen the research and development of new drugs, speed up the progress of research and development, improve the level of research and development, and seize the market with innovative drugs; deepen strategic cooperation with universities and scientific research institutes, and use brains to attract wisdom to achieve mutual benefit and win-win; continue to promote green and environmentally friendly production to ensure safe and standardized growth; promote corporate culture, promote the growth of employees, and enhance employees' sense of identity and belonging to the company; strengthen the leadership of party building, establish a spirit of responsibility, and cultivate the idea of employees and the company to advance and retreat together, and share honor and disgrace, Create a good atmosphere of clean and upright.
Jiang Xiaomeng stressed that the realization of the grand blueprint for the future of the peak requires the joint efforts of every peak person. He hoped that all cadres and employees would show greater energy and courage in their future work to create a better tomorrow for the peak and themselves. (this newspaper reporter)
More information
Two Cement Enterprises Prosperous Production and Sales in May
With the gradual easing of the new crown epidemic, all over the project has started, Hubei, Yunnan two provinces cement market continued to improve, Daye peak cement company, Yunnan peak cement company two enterprises have recently shown a good momentum of production and sales. In May, the sales volume of Yunnan Jianfeng cement continued to rise. As of the time of publication, the average daily shipment volume reached more than 7400 tons, and the highest daily shipment volume reached more than 8700 tons, and the production capacity was fully released. Over the past few days, Yunnan Peak Packaging System has made great efforts to overcome the impact of narrow distribution sites and many cement varieties to ensure the completion of delivery tasks with good quality and quantity every day. In order to further balance production and sales and create conditions for the homogenization of cement delivered from the factory, Yunnan peak packaging system puts forward work requirements for relevant posts, emphasizes equipment inspection and process inspection during production, strictly implements safety operation procedures, and maintains safe and efficient operation of the system. Due to the impact of the new crown epidemic, Hubei cement market started late, Wuhan market is the hardest hit area, the current project construction is still not fully started, the volume pressure is greater. For this reason, daye peak departments cooperate closely, increase market development efforts, develop new mixing stations, focus on increasing the bulk share of Xianning, Huanggang and Wuhan markets, seize the opportunity of fine weather, and achieve the goal of rapid output. Internally, on the basis of equipment technical renovation and production capacity improvement, the delivery is effectively guaranteed, and the daily delivery capacity can basically be maintained at 10,000 tons. In May, Daye Peak sold more than 300000 tons of cement, an increase of 20% over the same period last year, with an average daily sales volume of more than 9900 tons, the highest in the current period since Daye Peak was put into production.
2020
07-31
The company's "safe production month" activities are about to start
June 2020 is the 19th national "safe production month", the theme of the activity is "eliminating hidden dangers of accidents and building a strong line of defense". A few days ago, the group company issued a notice to arrange the activities related to the organization of "safe production month" and put forward requirements. According to the group's "safe production month" activity plan, different key thematic activities will be held in the four weeks of June. The first week is the "Publicity and Safety Education Week", which focuses on the use of WeChat groups, electronic screens, publicity boards, banners, slogans and other forms for safety publicity, and organizes the study of national safety regulations, company safety system specifications and accident-free factory creation standards, Organize to watch safety warning education films, learn accident cases, etc., and improve employees' safety awareness by creating a safety atmosphere and organizing learning activities. The focus of the activities in the second week is "looking for potential sources of danger around you". Each unit takes departments and teams as units to investigate and analyze the potential risk factors in the process of daily production, maintenance and operation, find out the hazard sources that have not been included in the scope of risk point control, and report to the safety management department of the unit to form a risk assessment report, put forward solutions or suggestions, and supervise the implementation of rectification and timely eliminate potential safety hazards. The third week is the "on-site safety innovation achievements exhibition week", which focuses on the achievements of each unit in on-site safety management and on-site safety facilities in the past year, which are displayed in the form of pictures and texts through beautiful articles and wechat, so as to learn from each other and promote common progress. The fourth week is the "safety training and drill week", and the group company organizes the standardization of safety production and the elimination of hidden dangers.
2020
07-31
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-31
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-30
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-22
On April 24, Jiang Xiaomeng, chairman of the group company, presided over the 14th meeting of the 10th board of directors of the company, and deliberated and passed 14 related reports and motions such as the 2019 annual board of directors report, the 2019 general manager business report and the 2019 annual report. The general manager's report pointed out that 2019 is the first year of the implementation of the group's new five-year strategic development plan (2019-2023) and the new three-year business plan (2019-2021) for each business sector. the management team has carried out various operation and management work in an orderly manner around the general policy of "innovation and reform, integration and promotion, scientific layout and steady development", and has better completed the business objectives set by the board of directors at the beginning of the year. In the whole year, the company achieved a total operating income of 3.548 billion billion yuan, an increase of 5.51 percent over the same period last year; net profit attributable to shareholders was 0.725 billion billion yuan, with earnings per share reaching 2.11 billion yuan, an increase of 23.14 percent over the same period last year, a record high; total assets at the end of the year were 5.475 billion billion yuan, an increase of 11.71 percent over the same period last year; and net assets attributable to shareholders were 3.789 billion billion yuan, an increase of 19.81 percent. During the reporting period, the company's two main businesses have achieved great development, benefiting from the further promotion of supply-side structural reform, the overall operation of the cement industry in 2019 is stable, and the industry benefits are further improved. During the reporting period, the company made new progress in the construction of cement projects, completed the acquisition, capital increase and name change of Guizhou Mingchuan (Guizhou Huangping Jianfeng Cement Co., Ltd.), and continued to invest in the construction of its new dry cement production line with a daily output of 4500 tons of clinker.
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page